Literature DB >> 6953748

Chlorpropamide-alcohol flushing in relation to macroangiopathy and peripheral neuropathy in non-insulin dependent diabetes.

P Jerntorp, L O Almér.   

Abstract

Seventy patients with non-insulin dependent diabetes (NIDD) were studied for the chlorpropamide-alcohol flush (CPAF), first degree family history of diabetes, macroangiopathy and for peripheral neuropathy. Positive CPAF challenge tests were found in 65% of the tested subjects and in 77% if there was a family history of diabetes. Signs of macroangiopathy (loss of foot pulses) were significantly (p less than 0.05) less common in the CPAF positive than in the CPAF negative diabetics with a duration of diabetes of ten years or less. With a longer duration this difference between the two groups was reduced. Also signs of peripheral neuropathy (abnormal vibration sense) were less common (p less than 0.05) in the CPAF positive diabetics than in the CPAF negative. Previously a low prevalence of retinopathy in teh CPAF positive non-insulin dependent diabetics has been reported. We have shown that this is also true of peripheral macroangiopathy and peripheral neuropathy. Chlorpropamide-alcohol flushing seems to be related to a relative protection against late complications in diabetes and the test might be used to find patients at risk.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6953748     DOI: 10.1111/j.0954-6820.1982.tb07698.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  8 in total

1.  Chlorpropamide-alcohol flush: a critical reappraisal.

Authors:  R M Hillson; T D Hockaday
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

2.  To flush or not to flush? Comments on the chlorpropamide-alcohol flush.

Authors:  W Waldhäusl
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

Review 3.  Chlorpropamide--alcohol flush: the case in favour.

Authors:  C Johnston; P G Wiles; D A Pyke
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

4.  Roles of chlorpropamide, alcohol and acetaldehyde in determining the chlorpropamide-alcohol flush.

Authors:  L Groop; C J Eriksson; R Huupponen; R Ylikahri; R Pelkonen
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

5.  Genetic and metabolic risk factors for the development of late complications in type I (insulin-dependent) diabetes.

Authors:  A E Pontiroli; A Calderara; L Bonisolli; P Maffi; A De Pasqua; A Margonato; G Radaelli; G Gallus; G Pozza
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

6.  Chlorpropamide-alcohol flush: significance of body weight, sex and serum chlorpropamide level.

Authors:  L Groop; C J Eriksson; E Wåhlin-Boll; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Plasma chlorpropamide: a critical factor in chlorpropamide-alcohol flush.

Authors:  P Jerntorp; L O Almér; H Ohlin; E Wåhlin-Boll; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 8.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.